Mosaic Therapeutics appoints Dr Barry Davies as CSO

FHS
October 8, 2024
10:37 am

Dr. Barry Davies joins Mosaic Therapeutics as CSO, bringing 25 years of drug discovery expertise to advance targeted oncology therapies and precision medicine.

Mayor of Minneapolis Issues Executive Order Making Psychedelics The City’s ‘Lowest Law Enforcement Priority’ | Psychedelic Spotlight

The mayor of Minneapolis, Mayor Jacob Frey (D), has signed an executive order that makes the possession, use, and cultivation of psychedelics the lowest priority

July 24, 2023

First-ever clinical trials evaluate fenofibrate as treatment for HPV-related cancers

A team from University Hospitals Seidman Cancer Center is launching the nation’s first-ever clinical trials evaluating the cholesterol drug fenofibrate (Triglide, Fibricor, Lipofen) as an

February 28, 2025

Novel method to deliver drugs into inner ear restores hearing in deaf mice

An international team of researchers has developed a new method to deliver drugs into the inner ear. The discovery was possible by harnessing the natural

June 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.